Frazier Life Sciences is a global investment firm focused on private and public biopharmaceutical companies across discovery, development, and commercialization stages. The firm deploys capital through venture funds and long-only public strategies, leveraging a team of investment partners and operating professionals with deep sector expertise in drug development, regulatory pathways, and commercial execution. Since 2016, Frazier Life Sciences has raised over $5.3 billion and established a track record of supporting company formation, having launched 25 entities since 2020. The firm's model emphasizes hands-on engagement and collaborative value creation with portfolio companies, combining fin...
Asset class
Impact theme
Investment geographies
